-
A414135-5mgInformationABBV-744 ABBV-744 is a BDII-selective BET bromodomain inhibitor that inhibits BRD2, BRD3 and BRD4. It is developed for treating AML and cancers.TargetsBDIIIn vitroABBV-744 is a potent inhibitor specific for BDII of BRD2/3/4, with
-
A607323-25mgABBV-CLS-484.
-
A607323-5mgABBV-CLS-484.
-
-
-
-
-
-
-
-
-